Why the study?
Ischemic mitral regurgitation is associated with poor outcomes despite initial repair, and prior intermediate-term results of posterior leaflet augmentation lacked follow-up beyond 4 years.
Does surgical mitral valve repair using posterior leaflet extension with a bovine pericardial patch and a true-sized remodeling annuloplasty ring provide long-term durability and survival in patients with severe Carpentier Type IIIb ischemic mitral regurgitation?
Does surgical mitral valve repair using posterior leaflet extension with a bovine pericardial patch and a true-sized remodeling annuloplasty ring provide long-term durability and survival in patients with severe Carpentier Type IIIb ischemic mitral regurgitation?
Posterior mitral leaflet extension with a bovine pericardial patch and true-sized annuloplasty ring for severe Type IIIb ischemic mitral regurgitation provides durable long-term valve competence (71.3% freedom from moderate-to-severe MR at 10 years), though 10-year survival remains low (43.3%) primarily due to non-cardiac causes.
Answers are grounded in this paper and cite their sources.
Posterior leaflet augmentation may yield durable repair in ischemic MR survivors; leaves open need for randomized trials versus standard annuloplasty.
Objective: Ischemic mitral regurgitation (MR) is generally associated with very poor outcomes and disappointing results, despite a seemingly perfect initial repair and optimal revascularization. We previously published our intermediate-term results of posterior leaflet augmentation without follow-up extending beyond 4 years. Our objective is to assess long-term durability of the repair, survival, and the causes of late mortality. Methods: Ninety-one patients with severe (4+) Carpentier Type IIIb ischemic MR underwent repair in a single center between 2003 and 2022 by method of posterior leaflet extension using a patch of bovine pericardium and a true-sized remodeling annuloplasty ring, with or without surgical revascularization. Serial echocardiography was performed over the years to ascertain valve competence and degree of ventricular remodeling, in addition to telephone follow-up and chart reviews. Results: The average age of patients was 67 ± 9.6 years. Mean follow-up was 8 ± 5 years with some extending to almost 20 years. One-, 5-, and 10-year freedom from recurrent significant MR, characterized as moderate or severe MR, was 98.6%, 85.5%, and 71.3%, respectively. Thirty-day mortality was 6.5%. One-, 5-, and 10-year survival was 85.5%, 64.4%, and 43.3%, respectively. Of all the mortalities, only 17.5% were proven to be directly cardiac related. Conclusions: The suggested repair technique offers satisfactory long-term outcomes with minimal residual regurgitation in surviving patients when used in context of ischemic MR. Despite durable repair, we have discovered that poor long-term survival is not directly related to cardiovascular causes.
No takes yet. Share an insight, caveat, or question.
Alsheebani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: